CARASENT ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.3 NOK | -4.67% |
|
+34.91% | +29.29% |
| Apr. 24 | Carasent ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Transcript : Carasent ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
Presenter SpeechDaniel Ohman (Executives)Hi, and welcome to Carasent's Capital Markets Day. Re...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.
Sector
IT Services & Consulting
Calendar
2024-07-11
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.3
NOK
Average target price
25.5
NOK
Spread / Average Target
+78.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.29% | 93.65M | |
| -12.23% | 194B | |
| +0.74% | 166B | |
| +2.19% | 153B | |
| +4.34% | 99.85B | |
| +7.04% | 77.56B | |
| +19.09% | 73.55B | |
| -7.30% | 71B | |
| -20.54% | 52.81B | |
| +0.53% | 47.86B |
- Stock Market
- Equities
- CARA Stock
- News Carasent ASA
- Transcript : Carasent ASA - Analyst/Investor Day
